PaxMedica Inc. (NASDAQ: PXMD) Developing Treatments for Underserved Neurological Disorders
PaxMedica is preparing to submit a New Drug Application to the U.S. Food and Drug Administration for suramin to treat…
PaxMedica is preparing to submit a New Drug Application to the U.S. Food and Drug Administration for suramin to treat…
Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has received an order for 29 Mullen GOS from one of…
Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded mineral exploration company exploring for high-grade copper and gold…
Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease…
New York City has received lots of backlash, mainly from People for the Ethical Treatment of Animals (“PETA”), for its…
Age-related macular degeneration is a disease significantly impacting the quality of life, making it difficult for individuals to perform everyday…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that its subsidiary, Bollinger Motors, released its full…
The new executive team includes Mark White, Alexander Morin, Hilda Maibach, and Blake Jensen These additions are pivotal as the…
CNM-Au8(R) works by improving cellular energy production and utilization, which is crucial for maintaining neuronal health Clene has conducted several…
Meta Platforms (NASDAQ: META), a leading tech giant known for its social media platforms such as Facebook, Instagram, and WhatsApp,…